388 related articles for article (PubMed ID: 7761145)
1. Drug-resistant malaria in children and in travelers.
Longworth DL
Pediatr Clin North Am; 1995 Jun; 42(3):649-64. PubMed ID: 7761145
[TBL] [Abstract][Full Text] [Related]
2. Chloroquine resistant malaria in children.
Memon IA; Kanth N; Murtaza G
J Pak Med Assoc; 1998 Apr; 48(4):98-100. PubMed ID: 9783043
[TBL] [Abstract][Full Text] [Related]
3. Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control.
Gama BE; Lacerda MV; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1():159-66. PubMed ID: 21881770
[TBL] [Abstract][Full Text] [Related]
4. [Plasmodium resistance to antimalarials].
Cailhol J; Consigny PH
Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
[No Abstract] [Full Text] [Related]
5. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
6. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.
Fryauff DJ; Sumawinata I; Purnomo ; Richie TL; Tjitra E; Bangs MJ; Kadir A; Ingkokusumo G
Am J Trop Med Hyg; 1999 Apr; 60(4):542-6. PubMed ID: 10348226
[TBL] [Abstract][Full Text] [Related]
7. [Does the brief treatment with antimalarials favorably influence drug resistance and recurrences?].
Kroeger A
Rev Panam Salud Publica; 2001 Mar; 9(3):202-4. PubMed ID: 11349355
[No Abstract] [Full Text] [Related]
8. Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.
Wirjanata G; Handayuni I; Prayoga P; Leonardo L; Apriyanti D; Trianty L; Wandosa R; Gobay B; Kenangalem E; Poespoprodjo JR; Noviyanti R; Kyle DE; Cheng Q; Price RN; Marfurt J
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533239
[TBL] [Abstract][Full Text] [Related]
9. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
10. The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia.
Fryauff DJ; Leksana B; Masbar S; Wiady I; Sismadi P; Susanti AI; Nagesha HS; Syafruddin ; Atmosoedjono S; Bangs MJ; Baird JK
Ann Trop Med Parasitol; 2002 Jul; 96(5):447-62. PubMed ID: 12194705
[TBL] [Abstract][Full Text] [Related]
11. Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax.
Bustamante C; Batista CN; Zalis M
Curr Drug Targets; 2009 Mar; 10(3):279-90. PubMed ID: 19275564
[TBL] [Abstract][Full Text] [Related]
12. The antimalarial ferroquine: from bench to clinic.
Biot C; Nosten F; Fraisse L; Ter-Minassian D; Khalife J; Dive D
Parasite; 2011 Aug; 18(3):207-14. PubMed ID: 21894260
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
14. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance in malaria.
White NJ
Br Med Bull; 1998; 54(3):703-15. PubMed ID: 10326295
[TBL] [Abstract][Full Text] [Related]
16. Reversal of Chloroquine Resistance of Plasmodium vivax in Aotus Monkeys.
Obaldia N; Milhous WK; Kyle DE
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941642
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India.
Nandy A; Addy M; Maji AK; Bandyopadhyay AK
Ann Trop Med Parasitol; 2003 Apr; 97(3):215-20. PubMed ID: 12803853
[TBL] [Abstract][Full Text] [Related]
18. Malaria Surveillance - United States, 2015.
Mace KE; Arguin PM; Tan KR
MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
[TBL] [Abstract][Full Text] [Related]
19. [The current status of the resistance of malaria pathogens to antimalarials].
Kondrashin AV; Baranova AM; Morozov EN; Morozova LF; Stepanova EV
Med Parazitol (Mosk); 2014; (3):51-7. PubMed ID: 25286554
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin combination therapy for vivax malaria.
Douglas NM; Anstey NM; Angus BJ; Nosten F; Price RN
Lancet Infect Dis; 2010 Jun; 10(6):405-16. PubMed ID: 20510281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
